Advisory Services Network’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.9M Buy
122,841
+4,540
+4% +$977K 0.35% 47
2026
Q1
$25.7M Sell
118,301
-9,864
-8% -$2.19M 0.34% 44
2025
Q4
$29.3M Buy
128,165
+2,862
+2% +$652K 0.41% 33
2025
Q3
$29M Sell
125,303
-11,778
-9% -$2.4M 0.43% 29
2025
Q2
$25.9M Buy
137,081
+12,033
+10% +$2.24M 0.42% 34
2025
Q1
$26.2M Buy
125,048
+6,540
+6% +$1.27M 0.5% 25
2024
Q4
$21.1M Sell
118,508
-22,730
-16% -$4.18M 0.39% 40
2024
Q3
$24.2M Hold
141,238
0.5% 25
2024
Q2
$24.2M Buy
141,238
+7,181
+5% +$1.19M 0.5% 25
2024
Q1
$24.4M Buy
134,057
+22,880
+21% +$3.94M 0.54% 21
2023
Q4
$17.2M Sell
111,177
-10,233
-8% -$1.49M 0.42% 34
2023
Q3
$18.1M Sell
121,410
-11,236
-8% -$1.65M 0.49% 28
2023
Q2
$17.9M Sell
132,646
-2,572
-2% -$377K 0.48% 28
2023
Q1
$21.5M Buy
135,218
+7,065
+6% +$1.08M 0.6% 15
2022
Q4
$20.7M Sell
128,153
-4,949
-4% -$759K 0.63% 13
2022
Q3
$17.9M Buy
133,102
+2,338
+2% +$336K 0.63% 16
2022
Q2
$20M Buy
130,764
+25,173
+24% +$3.85M 0.69% 13
2022
Q1
$17.1M Sell
105,591
-1,487
-1% -$216K 0.5% 23
2021
Q4
$14.5M Buy
107,078
+7,217
+7% +$853K 0.42% 31
2021
Q3
$10.8M Sell
99,861
-1,697
-2% -$194K 0.34% 48
2021
Q2
$11.4M Buy
101,558
+12,816
+14% +$1.44M 0.36% 40
2021
Q1
$9.6M Buy
88,742
+5,988
+7% +$640K 0.36% 43
2020
Q4
$8.87M Sell
82,754
-5,184
-6% -$498K 0.36% 49
2020
Q3
$7.7M Sell
87,938
-3,153
-3% -$297K 0.36% 52
2020
Q2
$8.94M Buy
91,091
+12,716
+16% +$1.12M 0.49% 30
2020
Q1
$5.97M Buy
78,375
+17,279
+28% +$1.47M 0.39% 48
2019
Q4
$5.41M Buy
61,096
+14,226
+30% +$1.18M 0.28% 75
2019
Q3
$3.41M Hold
46,870
0.21% 122
2019
Q2
$3.41M Buy
46,870
+4,380
+10% +$344K 0.21% 122
2019
Q1
$3.42M Buy
42,490
+1,283
+3% +$105K 0.24% 108
2018
Q4
$3.8M Sell
41,207
-1,366
-3% -$120K 0.33% 60
2018
Q3
$4.03M Sell
42,573
-625
-1% -$59.3K 0.29% 79
2018
Q2
$4.06M Sell
43,198
-9,524
-18% -$930K 0.31% 70
2018
Q1
$4.99M Buy
52,722
+2,096
+4% +$230K 0.4% 44
2017
Q4
$4.9M Buy
50,626
+11,512
+29% +$1.08M 0.43% 35
2017
Q3
$3.48M Buy
39,114
+6,824
+21% +$519K 0.4% 46
2017
Q2
$2.34M Buy
32,290
+2,143
+7% +$144K 0.31% 74
2017
Q1
$1.96M Buy
+30,147
New +$1.9M 0.29% 77
2016
Q3
$586K Buy
9,290
+5,555
+149% +$360K 0.11% 258
2016
Q2
$231K Sell
3,735
-118
-3% -$7.19K 0.05% 416
2016
Q1
$220K Buy
3,853
+303
+9% +$16.9K 0.06% 371
2015
Q4
$210K Sell
3,550
-222
-6% -$12.8K 0.07% 325
2015
Q3
$205K Sell
3,772
-10,005
-73% -$651K 0.06% 278
2015
Q2
$944K Buy
13,777
+9,997
+264% +$653K 0.28% 73
2015
Q1
$218K Sell
3,780
-4,833
-56% -$292K 0.06% 277
2014
Q4
$546K Buy
8,613
+4,158
+93% +$262K 0.17% 133
2014
Q3
$257K Sell
4,455
-506
-10% -$28.1K 0.09% 223
2014
Q2
$280K Buy
4,961
+943
+23% +$49.5K 0.12% 196
2014
Q1
$207K Buy
4,018
+147
+4% +$7.43K 0.11% 192
2013
Q4
$204K Buy
+3,871
New +$190K 0.1% 173

Other funds holding ABBV

Advisory Services Network's ABBV Position: Q2 2026 in Review

Advisory Services Network increased its AbbVie (ABBV) stake by 3.8% in Q2 2026, buying an estimated $977K and bringing the position to 122,841 shares worth $30.9M. The position accounts for 0.35% of the portfolio, ranked #47.

Advisory Services Network first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Advisory Services Network held 122,841 shares of AbbVie worth $30.9M as of Q2 2026.
  • Advisory Services Network bought 4,540 AbbVie shares in Q2 2026, an estimated $977K.
  • AbbVie made up 0.35% of Advisory Services Network's portfolio in Q2 2026, its #47 holding.
  • Advisory Services Network first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.